GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults

Recombinant human GH (rhGH) has been in use for 30 years, and over that time its safety and efficacy in children and adults has been subject to considerable scrutiny. In 2001, a statement from the GH Research Society (GRS) concluded that ‘for approved indications, GH is safe’; however, the statement...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Eur J Endocrinol
المؤلفون الرئيسيون: Allen, D B, Backeljauw, P, Bidlingmaier, M, Biller, B M K, Boguszewski, M, Burman, P, Butler, G, Chihara, K, Christiansen, J, Cianfarani, S, Clayton, P, Clemmons, D, Cohen, P, Darendeliler, F, Deal, C, Dunger, D, Erfurth, E M, Fuqua, J S, Grimberg, A, Haymond, M, Higham, C, Ho, K, Hoffman, A R, Hokken-Koelega, A, Johannsson, G, Juul, A, Kopchick, J, Lee, P, Pollak, M, Radovick, S, Robison, L, Rosenfeld, R, Ross, R J, Savendahl, L, Saenger, P, Toft Sorensen, H, Stochholm, K, Strasburger, C, Swerdlow, A, Thorner, M
التنسيق: Artigo
اللغة:Inglês
منشور في: Bioscientifica Ltd 2015
الموضوعات:
Position Statement
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4674592/
https://ncbi.nlm.nih.gov/pubmed/26563978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EJE-15-0873
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة